News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Photo taken from: https://ascopubs.org/doi/10.1200/JCO.23.02166
Mar 31, 2024, 23:12

Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology

Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center, posted on X:

“Results from phase III CONTACT-01 trial Journal of Clinical Oncology. Randomized 186 pts with NSCLC and prior chemo and immunotherapy to either atezolizumab + cabozantinib or standard docetaxel. Atezo/cabo did not improve OS (10.7m vs 10.5m, HR 0.88, ns) & was more toxic.”

Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Source: Stephen V Liu/X

cancer chemotherapy immunotherapy Journal of Clinical Oncology NSCLC OncoDaily Oncology Research Stephen V Liu
Special Coverage
Blog
Mar 22, 2025, 10:38
Emily Drake: I am an invited speaker 2025 Canadian Society of Palliative Medicine conference
Blog
Mar 22, 2025, 10:34
Gianluca Giannarini: Rapid-fire debates bladder cancer at EAU 2025
Blog
Mar 22, 2025, 10:21
Sibylle Loibl: Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases
Blog
Mar 22, 2025, 10:19
Dégi László Csaba: Proud to be one of the 9 European experts for the CCI4EU Project's 'Deep Dive' into Precision Cancer Medicine
Blog
Mar 22, 2025, 10:10
Corinne Leach: Innovation in Action at the CancerX Accelerator Moffitt Innovation Summit
Blog
Mar 22, 2025, 09:58
One story can change medical practice - EGFR Positive Lung Cancer UK
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab